![High uptake and use of vaginal ring for HIV prevention observed in open-label study | National Institutes of Health (NIH) High uptake and use of vaginal ring for HIV prevention observed in open-label study | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2018/20180306-woman-ring.jpg?itok=P3OHbcvi×tamp=1520352825)
High uptake and use of vaginal ring for HIV prevention observed in open-label study | National Institutes of Health (NIH)
![South Africa Approves Dapivirine Vaginal Ring for Use by Women | International Partnership For Microbicides South Africa Approves Dapivirine Vaginal Ring for Use by Women | International Partnership For Microbicides](https://www.ipmglobal.org/sites/default/files/image/publication/110a4095_0.jpg)
South Africa Approves Dapivirine Vaginal Ring for Use by Women | International Partnership For Microbicides
![Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention | AIDS and Behavior Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention | AIDS and Behavior](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10461-021-03542-z/MediaObjects/10461_2021_3542_Fig1_HTML.jpg)
Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention | AIDS and Behavior
Cde, on X: "For those asking; what is Dapivirine Ring?! Dapivirine vaginal ring, is a flexible silicon ring, inserted into the vagina where it slowly releases the antiretroviral drug dapivirine over an
![Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study - The Lancet HIV Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study - The Lancet HIV](https://www.thelancet.com/cms/attachment/7b4d3644-044a-42c4-8596-138cc2ac5e2a/gr1.jpg)
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study - The Lancet HIV
![InfoNile on X: "Edit Tweet: The dapivirine ring reduces HIV/AIDS contraction by 50%. In 2018 , there were 800,000 HIV cases in Sub-Saharan Africa; of those, 208,000 were women between 15-24 years ( InfoNile on X: "Edit Tweet: The dapivirine ring reduces HIV/AIDS contraction by 50%. In 2018 , there were 800,000 HIV cases in Sub-Saharan Africa; of those, 208,000 were women between 15-24 years (](https://pbs.twimg.com/media/FThO6riWUAMQrf2.jpg:large)